198 related articles for article (PubMed ID: 27346197)
1. Generation of a human iPSC line from a patient with an optic atrophy 'plus' phenotype due to a mutation in the OPA1 gene.
Galera-Monge T; Zurita-Díaz F; Moreno-Izquierdo A; Fraga MF; Fernández AF; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2016 May; 16(3):673-6. PubMed ID: 27346197
[TBL] [Abstract][Full Text] [Related]
2. Generation of optic atrophy 1 patient-derived induced pluripotent stem cells (iPS-OPA1-BEHR) for disease modeling of complex optic atrophy syndromes (Behr syndrome).
Hauser S; Schuster S; Theurer Y; Synofzik M; Schöls L
Stem Cell Res; 2016 Sep; 17(2):426-429. PubMed ID: 27879217
[TBL] [Abstract][Full Text] [Related]
3. Generation of a human iPSC line from a patient with a defect of intergenomic communication.
Zurita F; Galera T; González-Páramos C; Moreno-Izquierdo A; Schneiderat P; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):120-3. PubMed ID: 27345795
[TBL] [Abstract][Full Text] [Related]
4. Generation of a human iPSC line from a patient with a mitochondrial encephalopathy due to mutations in the GFM1 gene.
Zurita-Díaz F; Galera-Monge T; Moreno-Izquierdo A; Fraga MF; Ayuso C; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):124-7. PubMed ID: 27345796
[TBL] [Abstract][Full Text] [Related]
5. Establishment of a human DOA 'plus' iPSC line, IISHDOi003-A, with the mutation in the OPA1 gene: c.1635C>A; p.Ser545Arg.
Zurita-Díaz F; Galera-Monge T; Moreno-Izquierdo A; Corton M; Ayuso C; Garesse R; Gallardo ME
Stem Cell Res; 2017 Oct; 24():81-84. PubMed ID: 29034899
[TBL] [Abstract][Full Text] [Related]
6. Generation of a disease-specific iPS cell line derived from a patient with Charcot-Marie-Tooth type 2K lacking functional GDAP1 gene.
Martí S; León M; Orellana C; Prieto J; Ponsoda X; López-García C; Vílchez JJ; Sevilla T; Torres J
Stem Cell Res; 2017 Jan; 18():1-4. PubMed ID: 28395795
[TBL] [Abstract][Full Text] [Related]
7. Generation of an iPSC line from a patient with GTP cyclohydrolase 1 (GCH1) deficiency: HDMC0061i-GCH1.
Jung-Klawitter S; Ebersold J; Göhring G; Blau N; Opladen T
Stem Cell Res; 2017 Apr; 20():38-41. PubMed ID: 28395739
[TBL] [Abstract][Full Text] [Related]
8. Derivation of a human DOA iPSC line, IISHDOi006-A, with a mutation in the ACO2 gene: c.1999G>A; p.Glu667Lys.
Cerrada V; García-López M; Moreno-Izquierdo A; Villaverde C; Zurita O; Martin-Merida MI; Arenas J; Ayuso C; Gallardo ME
Stem Cell Res; 2019 Oct; 40():101566. PubMed ID: 31509793
[TBL] [Abstract][Full Text] [Related]
9. Generation of a human induced pluripotent stem cell line PUMCHi019-A from a dominant optic atrophy patient with an OPA1 mutation.
Sun Z; Wu S; Zhu T; Wei X; Han X; Zou X; Sui R
Stem Cell Res; 2022 Apr; 60():102705. PubMed ID: 35152176
[TBL] [Abstract][Full Text] [Related]
10. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
11. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
12. Generation of human iPS cell line CTL07-II from human fibroblasts, under defined and xeno-free conditions.
Kele M; Day K; Rönnholm H; Schuster J; Dahl N; Falk A
Stem Cell Res; 2016 Nov; 17(3):474-478. PubMed ID: 27789397
[TBL] [Abstract][Full Text] [Related]
13. Generation of iPSC line iPSC-FH2.1 in hypoxic conditions from human foreskin fibroblasts.
Questa M; Romorini L; Blüguermann C; Solari CM; Neiman G; Luzzani C; Scassa MÉ; Sevlever GE; Guberman AS; Miriuka SG
Stem Cell Res; 2016 Mar; 16(2):300-3. PubMed ID: 27345989
[TBL] [Abstract][Full Text] [Related]
14. Generation of a human induced pluripotent stem cell (iPSC) line from a patient carrying a P33T mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):273-276. PubMed ID: 27879211
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell (iPSC) line from a patient with family history of diabetes carrying a C18R mutation in the PDX1 gene.
Wang X; Chen S; Burtscher I; Sterr M; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Lickert H
Stem Cell Res; 2016 Sep; 17(2):292-295. PubMed ID: 27879214
[TBL] [Abstract][Full Text] [Related]
16. Generation of iPSC line HEL47.2 from healthy human adult fibroblasts.
Trokovic R; Weltner J; Otonkoski T
Stem Cell Res; 2015 Jul; 15(1):263-5. PubMed ID: 26096151
[TBL] [Abstract][Full Text] [Related]
17. Generation of a gene-corrected isogenic control cell line from an Alzheimer's disease patient iPSC line carrying a A79V mutation in PSEN1.
Pires C; Schmid B; Petræus C; Poon A; Nimsanor N; Nielsen TT; Waldemar G; Hjermind LE; Nielsen JE; Hyttel P; Freude KK
Stem Cell Res; 2016 Sep; 17(2):285-288. PubMed ID: 27879212
[TBL] [Abstract][Full Text] [Related]
18. Generation of a human iPSC line from a patient with Leigh syndrome.
Galera T; Zurita F; González-Páramos C; Moreno-Izquierdo A; Fraga MF; Fernández AF; Garesse R; Gallardo ME
Stem Cell Res; 2016 Jan; 16(1):63-6. PubMed ID: 27345786
[TBL] [Abstract][Full Text] [Related]
19. Generation and characterization of human iPSC lines derived from a Primary Hyperoxaluria Type I patient with p.I244T mutation.
Zapata-Linares N; Rodriguez S; Salido E; Abizanda G; Iglesias E; Prosper F; Gonzalez-Aseguinolaza G; Rodriguez-Madoz JR
Stem Cell Res; 2016 Jan; 16(1):116-9. PubMed ID: 27345794
[TBL] [Abstract][Full Text] [Related]
20. Generation of human iPSCs from urine derived cells of a patient with a novel homozygous PAI-1 mutation.
Afzal MZ; Gartz M; Klyachko EA; Khan SS; Shah SJ; Gupta S; Shapiro AD; Vaughan DE; Strande JL
Stem Cell Res; 2016 Nov; 17(3):657-660. PubMed ID: 27934602
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
